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Despite a decline in incidence, gastric cancer remains a major cause
of death worldwide (Howson et al, 1986). About 10% of gastric
cancers are familial but the relative contributions of genetic and
environmental factors are poorly understood (Zanghieri et al, 1990;
La Vecchia et al, 1992). Over 90% of gastric cancers are adenocarci-
nomas. These can be classified according to differentiation and by
the histomorphological classification of Lauren (1965) which
divides tumours into ‘intestinal’ and ‘diffuse’. This appears to
reflect differences in the biological basis of the disease. Intestinal
tumours are often ulcerating, are associated with intestinal meta-
plasia of the stomach and are more common in men. Diffuse
tumours are poorly differentiated infiltrating lesions which predom-
inate in younger patients and exhibit a sex ratio close to unity
(Mecklin et al, 1988; Lo et al, 1996). Furthermore, diffuse cancers
are associated with a higher familial risk (Lehtola, 1978), suggesting
that genetic factors play a greater role in their development.
Whilst comparatively little is known about gastric carcino-
genesis, mutations in the calcium-dependent cell adhesion mole-
cule E-cadherin are associated with the early development of
gastric cancer, particularly those which are undifferentiated, diffuse
and invasive (Becker et al, 1994; Oda et al, 1994; Muta et al, 1996;
Tamura et al, 1996; Shiozaki et al, 1996). A recent study of two
families with familial gastric cancer has demonstrated that constitu-
tive mutations in the E-cadherin gene confer susceptibility to the
disease (Guilford et al, 1998). In one of the families a frameshift
mutation was identified in exon 15 which co-segregated with the
gastric cancer and in the second family affected individuals
harboured a premature stop codon interrupting exon 13. In order to
evaluate the contribution of germline mutations in E-cadherin to
the development of gastric cancer we have analysed blood samples
from a consecutive series of 106 patients with the disease.
PATIENTS AND METHODS
Patients
EDTA-venous blood samples were obtained from 106 patients
attending the Royal Marsden Hospital with a histologically proven
diagnosis of gastric adenocarcinoma. All blood samples were
obtained with informed consent and local ethical review board
approval. A family history was obtained from all patients. Of the
106 patients, 10 reported a family history of gastric cancer. DNA
was extracted from blood samples using a standard sucrose lysis
method.
Methods
The search for germline mutations in the E-cadherin gene was
performed using conformational specific gel electrophoresis
(CSGE). A combination of published and newly-designed
oligonucleotides was used to amplify each exon of E-cadherin
(including splice sites) specifically in the PCR (Table 1). CSGE
was performed as described by Ganguly et al (1993). All samples
with bandshifts were sequenced in duplicate and in forward and
reverse orientations after re-amplification of the appropriate exon
from genomic DNA in the PCR. Purified PCR products were
sequenced using the ABI Ready Reaction Dye Terminator Cycle
Sequencing kit and the ABI 377 Prism sequencer.
RESULTS AND DISCUSSION
Prompted by the recent report of two families in which constitu-
tive mutations in the E-cadherin gene predispose to gastric cancer
(Guilford et al, 1998), we have examined a consecutive series of
106 patients for germline mutations. The ages and clinical charac-
teristics of the patients are shown in Table 2.
The average age at diagnosis of the patients we studied is lower
than in the general population and they are therefore likely to
include a higher proportion of genetically susceptible individuals.
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Family histories were obtained from all patients and 10 reported a
history of gastric cancer in at least one relative. Details of these
familial cases are shown in Table 3. None of the cases studied had
family histories indicative of either hereditary nonpolyposis colon
cancer (HNPCC) or breast–ovarian cancer syndromes.
We have screened the full coding sequence and splice junctions
of E-cadherin for germline mutations in these 10 familial and 96
sporadic gastric cancer patients. No clearly disease-causing muta-
tions in the E-cadherin gene were identified in any of the 106
patients screened. Five variants were detected (Table 4). The two
variants in exons 13 and 14 have been previously reported
(Risinger et al, 1994; Berx et al, 1995). The polymorphism in exon
13 was a synonymous C–T substitution at position 3 of codon 692
encoding alanine, and the polymorphism in exon 14 was a synony-
mous C–T substitution at position 3 of codon 751 encoding aspar-
tine. The other three variants detected were in the 5¢ untranslated
region of exon 1 and have not been reported previously. It is
conceivable, but not likely, because none had a family history of
cancer, that the mutations we detected in the 5¢ untranslated region
of the gene might be pathogenic by affecting the expression of E-
cadherin either directly or through linkage disequilibrium with
other mutations affecting promotor function.
The results suggest that germline mutations in E-cadherin are
rare in gastric cancer patients. We cannot exclude the possibility
that a minority of mutations have been missed, but under test
conditions we have found that CSGE can detect all small inser-
tions or deletions and 90% of single base substitutions, and the
technique detected a number of single base substitution polymor-
phisms within the gene. Based on the number of gastric cancer
patients we have screened for constitutive mutations we can
conclude with 95% probability that germline variation in E-
cadherin will not account for more than 3% of all gastric cancers in
the British population.
The recent report demonstrating that constitutional mutations in
E-cadherin can confer a high gastric cancer risk was based on two
families from Aotearoa, New Zealand (Guilford et al, 1998).
Ninety per cent of affected individuals in these families were diag-
nosed before the age of 65, whereas gastric cancer in the general
population is usually diagnosed after the age of 65 and the pattern
of inheritance was clearly dominant with a penetrance of around
80% (Guilford et al, 1998). The patients we have studied were
from the United Kingdom and were not of comparable age, and
none had a family history clearly indicative of a dominant suscep-
tibility gene. Gastric cancers caused by E-cadherin may be
restricted to patients with very early onset disease and strong
family histories or from specific ethnic groups.
Although mutations in E-cadherin appear to be a rare cause of
gastric cancer they provide direct evidence for the existence of a
gastric cancer susceptibility syndrome. Prior to the report of
Guilford et al (1998) the only inherited forms of gastric cancer
Table 1 Primers and conditions used for PCR amplification of E-cadherin exons; adapted from Berx et al, 1995
Primer sequence Amplicon size TA MgCl2
(bp) (°C) (mM)
1-F TACGGGGGGCGGTGCTCCGG 282 68 2
1-R TCACCCGGTTCCATCTAC
2-F TCACCGGTTCCATCTAC 378 65/55 Td 2
2-R CAACCTCCTCTTCTTTAT
3-F GCTCTTGTCTTTAATCTGTC 360 65/55 Td 1.5
3-R GTACCAAGGCTGAGAAACCT
4 and 5-F CTTGTTCCTCATCTTCTTTC 603 65/55 Td 2
4 and 5-R CCCATCACTTCTCCTTAGAGCA
6-F CTCACTTGGTTCTTTCAG 246 55 1.5
6-R AACCTTTGGGCTTGGACA
7-F AGCTTGTCTAAACCTTCATC 329 65/55 Td 2
7-R GCTTAGACCATCACTGTATT
8-F TTGGTTGTGTCGATCTCTCT 223 60/50 Td 2.5
8-R CAGTGGTACCCTTAGTTCAT
9-F GTACTTGTAATGACACATCTC 252 55 2
9-R TGCCAGTTTCTGCATCTTGC
10-F ACTTCATTGTTTCTGCTCTC 311 65/55 Td 2
10-R AACCAGTTGCTGCAAGTCAG
11-F GTTGTTTGCTGGTCCTATTC 253 65/55 Td 2
11-R GAACTAGCTAGGAGGTCGAG
12-F TGGGGATTCATTACTGTTGC 326 65/55 Td 1.5
12-R GCATGGCAGTTGGAGCAAAG
13-F TTTCCTCCCCTGGTCTCATC 302 65/55 Td 2
13-R TGAGTCACTTGCCAGCTGGA
14-F CTCTCAACACTTGCTCTGTC 209 65/55 Td 1.5
14-R AGAGATCACCACTGAGCTAC
15-F CATAGCCCTGTGTGTATGAC 248 65/55 Td 1.5
15-R CGGATGCTTTGGCTTTCCAC
16-F AGATGACAGGTGTGCCCTTC 315 65/55 Td 1.5
16-R ATTTCTGCATTTCCCAGCAC
4/5–3a CTTTCATTTTGTCTTCAG 55 Td 1.5
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recognized were those in association with inherited cancer
syndromes such as HNPCC and BRCA2 (reviewed in Bevan and
Houlston, 1999). As E-cadherin appears to be central to the main-
tenance of gastric mucosa, mutations in genes such as a and b-
catenin, which can abolish E-cadherin mediated cell adhesion
(Ilyas and Tomlinson, 1997), represent other possible suscepti-
bility genes.
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Table 2 Ages and clinical characteristics of gastric cancer patients studied
Sex Male (85): Female (21)
Age; years (+/– SD)
All (n = 106) 61.2 (10.6)
Positive family history (n = 10) 53.6 (11.0)
No family history (n = 96) 62.0 (10.3)
Histology
Diffuse 26
Intestinal 43
Mixed 3
Unclassified 34
Table 3 Details of patients with a family history of gastric cancer
Index case (age; years) Relative (age; years)
45 Father (33)
59 Uncle (73)
45 Grandfather (77)
46 Father (66) and Mother (73)
47 Mother (80)
75 Brother (72)
59 Grandfather (70)
67 Grandfather (46)
52 Aunt (29)
41 Father (45)
Table 4 Summary of E-cadherin gene variations detected
No. Position (bp) Polymorphism Frequency
2 – 54; 5¢ UTR G > C 0.019
2 – 71; 5¢ UTR C > G 0.019
1 – 82; 5¢ UTR C > G 0.009
54 Codon 692 GCC(Ala) to GCT (Ala) 0.51
5 Codon 751 AAC(Asn) to AAT(Asn) 0.047